|Articles|November 1, 2018
- Pharmaceutical Executive-11-01-2018
- Volume 38
- Issue 11
Pharmaceutical Executive, November 2018 Issue (PDF)
Click the title above to open the Pharmaceutical November 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Pharm Exec's 2019 Pipeline Reportover 7 years ago
High-Risk Marketing Violations Draw Scrutinyover 7 years ago
Biopharma Business Checkover 7 years ago
Patent Protection for Cannabis?over 7 years ago
Steadying the Path of Good Scienceover 7 years ago
Southeast Biotech: Rising Tall in the Valleyover 7 years ago
Fighting for a Streamlined European HTA Schemeover 7 years ago
Stunted Innovation in Drug Development?over 7 years ago
Country Report: AlgeriaAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5